News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Ben Derman: Puzzling Together MRD Negativity and the ODAC Vote in Myeloma
Ben Derman/uchicagomedicine.org
Aug 27, 2025, 19:42

Ben Derman: Puzzling Together MRD Negativity and the ODAC Vote in Myeloma

Ben Derman, Assistant Professor at the University of Chicago, shared a post on X:

“You are not alone in wondering what the implications of the FDA ODAC vote last year are on MRD negativity (and CR) as a surrogate endpoint for clinical trials in myeloma.

I try to piece it together in this approachable primer for ASCO Daily News!”

Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington, shared this post, adding:

“Excellently written ASCO Daily News article by Ben Derman about the nuances of MRD in myeloma.

Including the clearest explanation of surrogate threshold effects I’ve seen – what ‘voltage’ of ∆ MRD neg is needed to predict ∆ PFS/OS?

Hopefully, MRD-guided approvals coming soon!”

Ben Derman: Puzzling Together MRD Negativity and the ODAC Vote in Myeloma

More posts featuring Ben Derman and Rahul Banerjee.

ASCO Daily News Ben Derman cancer Measurable residual disease MRD Myeloma OncoDaily Oncology Rahul Banerjee
Special Coverage
Voices
Aug 27, 2025, 19:42
Ben Derman: Puzzling Together MRD Negativity and the ODAC Vote in Myeloma
Voices
Aug 27, 2025, 19:33
Amy C. Moore: The Growing Concern of Early-Onset Cancer in Young Adults
Insight
Aug 27, 2025, 19:21
Raffaele Giusti: Buprenorphine is Not a First-Line Mandate in Cancer Pain
Insight
Aug 27, 2025, 19:03
Al-Ola Abdallah: New Data on Bispecific Antibodies in CNS Multiple Myeloma
Voices
Aug 27, 2025, 19:02
Francis Makokha Thanks Miriam Mutebi for Highlighting Personalized Medicine in Africa
Blog Posts
Aug 27, 2025, 18:43
Nina Niu Sanford: Kristen Ciombor Discusses the Pros and Cons of ctDNA Testing in Cancer Care
Opinion
Aug 27, 2025, 18:20
David Palma: Docetaxel and Skin Toxicity in Head and Neck Cancer
Voices
Aug 27, 2025, 18:03
Estela Rodriguez: Less than 2 Weeks to go for WCLC25
Voices
Aug 27, 2025, 17:48
Yvonne Diaz: Grateful to Be Part of ALK Positive and Oncogene Cancer Research
Science
Aug 27, 2025, 16:59
Naveen Pemmaraju: Final Results for Tagraxofusp in R/R Myelofibrosis
Science
Aug 27, 2025, 16:46
Varadha Balaji Venkadakrishnan: PROX1 - A Key Driver of Neuroendocrine Prostate Cancer
Voices
Aug 27, 2025, 16:34
Nico Gagelmann: Does HLA Matter In the PTCY Era? Join COSTEM to Know